Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part I: Haematological Studies)
https://doi.org/10.30895/1991-2919-2019-9-3-197-206
Abstract
Preclinical safety evaluation is an important stage in the development of medicinal products. Clinical laboratory studies, including haematological, biochemical and pathomorphological studies, are an essential part of chronic toxicity studies. A careful choice of methodological approaches to examination of toxicological characteristics of drug candidates makes it possible to assess the degree of risk associated with their subsequent clinical use, identify potential target organs, determine the extent of damage, as well as the possibility and dynamics of restoring damaged systems. Key prerequisites for obtaining adequate results of the studies are correct methodological implementation of all the stages of sample preparation and careful consideration of all factors during interpretation of the obtained data. Thus, the choice of methodological approaches to blood tests is often determined by the species, age and sex of laboratory animals, as well as by specific characteristics of the tested drug. The aim of the study was to summarise data on haematological studies performed in the Drug Toxicology Laboratory of the Federal State Budgetary Institute «Zakusov Institute of Pharmacology» when conducting chronic toxicity studies.
Keywords
About the Authors
A. V. SorokinaRussian Federation
Aleksandra V. Sorokina, Cand. Sci. (Biol.)
8 Baltiyskaya St., Moscow 125315
S. V. Alekseeva
Russian Federation
Svetlana V. Alekseeva
8 Baltiyskaya St., Moscow 125315
N. V. Eremina
Russian Federation
Natalia V. Eremina, Cand. Sci. (Biol.)
8 Baltiyskaya St., Moscow 125315
A. D. Durnev
Russian Federation
Andrey D. Durnev, Dr. Sci. (Med.), Professor, Corresponding Member of RAS
8 Baltiyskaya St., Moscow 125315References
1. Diehl K, Hull R, Morton В, Pfister R, Rabemampianina Y, Smith D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Tox. 2001;21(1):15-23. PMID: 11180276.
2. Caron A, Lelong C, Bartels T, Dorchies O, Gury T, Chalier C, Benning V. Clinical and anatomic pathology effects of serial blood sampling in rat toxicology studies, using conventional or microsampling methods. Regul Toxicol Pharmacol. 2015;72(3):429–39. https://doi.org/10.1016/j.yrtph.2015.05.022
3. McGuill MW, Rowan AN. Biological effects of blood loss: implications for sampling volumes and techniques. ILAR Journal. 1989;31(4):5–20. https://doi.org/10.1093/ilar.31.4.5
4. Zou W, Yang Y, Gu Y, Zhu P, Zhang M, Cheng Z, et al. Repeated blood collection from tail vein of non-anesthetized rats with a vacuum blood collection system. J Vis Exp. 2017;(130):e55852. https://doi.org/10.3791/55852
5. Poitout-Belissent F, Aulbach A, Tripathi N, Ramaiah L. Reducing blood volume requirements for clinical pathology testing in toxicologic studies-points to consider. Vet Clin Pathol. 2016;45(4):534–51. https://doi.org/10.1111/vcp.12429
Review
For citations:
Sorokina A.V., Alekseeva S.V., Eremina N.V., Durnev A.D. Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part I: Haematological Studies). The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2019;9(3):197-206. (In Russ.) https://doi.org/10.30895/1991-2919-2019-9-3-197-206